Compounds > 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate
Page last updated: 2024-11-05

8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Calcification, Pathologic

8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate has been researched along with Calcification, Pathologic in 1 studies

8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate: intracellular calcium antagonist; RN given refers to parent cpd

Research Excerpts

ExcerptRelevanceReference
" To investigate whether similar effects are present in the hippocampus, AMPA dose-response and calcium movement blockade were performed."1.35Nimodipine inhibits TMB-8 potentiation of AMPA-induced hippocampal neurodegeneration. ( Bernal, F; Mahy, N; Petegnief, V; Pugliese, M; Rodríguez, MJ; Ursu, G, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernal, F1
Petegnief, V1
Rodríguez, MJ1
Ursu, G1
Pugliese, M1
Mahy, N1

Other Studies

1 other study available for 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Calcification, Pathologic

ArticleYear
Nimodipine inhibits TMB-8 potentiation of AMPA-induced hippocampal neurodegeneration.
    Journal of neuroscience research, 2009, Volume: 87, Issue:5

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analysis of Variance; Animals; Anthraquino

2009